Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Future Oncology (London, England)
|
April 3, 2015
Adjuvant hormonal therapy and fertility preservation in premenopausal breast cancer: a survey among Italian oncologists
Sandro Barni, Elena Collovà, Antonio Frassoldati, et al.
Molecular Medicine Reports
|
April 9, 2011
Effect of peg-filgrastim-supported dose-dense adjuvant chemotherapy on the peripheral blood leukocyte phenotype in breast cancer patients
Elena Collovà, Bianca Rovati, Donatella Grasso, et al.
Cancer Immunology, Immunotherapy : CII
|
March 29, 2003
Lack of dendritic cell mobilization into the peripheral blood of cancer patients following standard- or high-dose chemotherapy plus granulocyte-colony stimulating factor
Silvia Ferrari, Bianca Rovati, Camillo Porta, et al.
Tumori
|
October 13, 2011
Use of metronomic chemotherapy in oncology: results from a national Italian survey
Elena Collovà, Federica Sebastiani, Elisabetta De Matteis, et al.
Oncology Reports
|
August 9, 2002
Impact of topotecan-based chemotherapy on the immune system of advanced ovarian cancer patients: an immunophenotypic study
Silvia Ferrari, Bianca Rovati, Lucia Cucca, et al.
Oncology
|
October 16, 2008
Biological effects of pegfilgrastim on circulating neutrophils in breast cancer patients undergoing dose-dense chemotherapy
Rosangela Invernizzi, Donatella Grasso, Erica Travaglino, et al.
Cancer Treatment Reviews
|
June 24, 2010
Anticancer oral therapy: emerging related issues
Giuseppe Luigi Banna, Elena Collovà, Vittorio Gebbia, et al.
Future Oncology (London, England)
|
November 20, 2015
Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: current status and future development
Marina E Cazzaniga, Andrea Camerini, Raffaele Addeo, et al.
Therapeutic Advances in Medical Oncology
|
April 2, 2021
Patterns of treatment and outcome of palbociclib plus endocrine therapy in hormone receptor-positive/HER2 receptor-negative metastatic breast cancer: a real-world multicentre Italian study
Raffaella Palumbo, Rosalba Torrisi, Federico Sottotetti, et al.
Journal for Immunotherapy of Cancer
|
September 1, 2025
Regulatory polymorphisms of <i>MSH6</i>, <i>MSH2</i>, <i>FBXO11,</i> and <i>PPP1R21</i> genes affect survival of patients with immunotherapy-treated lung cancer
Martina Esposito, Sara Noci, Francesca Minnai, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Future Oncology (London, England)
|
April 3, 2015
Adjuvant hormonal therapy and fertility preservation in premenopausal breast cancer: a survey among Italian oncologists
Sandro Barni, Elena Collovà, Antonio Frassoldati, et al.
Molecular Medicine Reports
|
April 9, 2011
Effect of peg-filgrastim-supported dose-dense adjuvant chemotherapy on the peripheral blood leukocyte phenotype in breast cancer patients
Elena Collovà, Bianca Rovati, Donatella Grasso, et al.
Cancer Immunology, Immunotherapy : CII
|
March 29, 2003
Lack of dendritic cell mobilization into the peripheral blood of cancer patients following standard- or high-dose chemotherapy plus granulocyte-colony stimulating factor
Silvia Ferrari, Bianca Rovati, Camillo Porta, et al.
Tumori
|
October 13, 2011
Use of metronomic chemotherapy in oncology: results from a national Italian survey
Elena Collovà, Federica Sebastiani, Elisabetta De Matteis, et al.
Oncology Reports
|
August 9, 2002
Impact of topotecan-based chemotherapy on the immune system of advanced ovarian cancer patients: an immunophenotypic study
Silvia Ferrari, Bianca Rovati, Lucia Cucca, et al.
Oncology
|
October 16, 2008
Biological effects of pegfilgrastim on circulating neutrophils in breast cancer patients undergoing dose-dense chemotherapy
Rosangela Invernizzi, Donatella Grasso, Erica Travaglino, et al.
Cancer Treatment Reviews
|
June 24, 2010
Anticancer oral therapy: emerging related issues
Giuseppe Luigi Banna, Elena Collovà, Vittorio Gebbia, et al.
Future Oncology (London, England)
|
November 20, 2015
Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: current status and future development
Marina E Cazzaniga, Andrea Camerini, Raffaele Addeo, et al.
Therapeutic Advances in Medical Oncology
|
April 2, 2021
Patterns of treatment and outcome of palbociclib plus endocrine therapy in hormone receptor-positive/HER2 receptor-negative metastatic breast cancer: a real-world multicentre Italian study
Raffaella Palumbo, Rosalba Torrisi, Federico Sottotetti, et al.
Journal for Immunotherapy of Cancer
|
September 1, 2025
Regulatory polymorphisms of <i>MSH6</i>, <i>MSH2</i>, <i>FBXO11,</i> and <i>PPP1R21</i> genes affect survival of patients with immunotherapy-treated lung cancer
Martina Esposito, Sara Noci, Francesca Minnai, et al.
Page
of 3